OGFR and gastric neoplasm: Methionine enkephalin (MENK), an endogenous opioid pentapeptide originating from proenkephalin A, has demonstrated the ability to elevate opioid growth factor receptor (OGFr) expression and inhibit PI3K/AKT/mTOR signaling in both TAMs and gastric tumor cells (86).